Sarah Haebe

Hematology/Oncology Fellow, PostDoc @StanfordMed

[Hidehito HORINOUCHI @HHorinouchi]

🔥@Nature_NPJ Precision Oncology🆙
✅Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patients
🎯Checkpoint inhibitors could play a critical role in treating NUT carcinoma
👥@SarahHaebe
#LCSM @OncoAlert #NUT #ICI
https://t.co/ilTZXw3qYR

[Sarah Haebe @SarahHaebe]

@zauggj @UniBasel_en Congrats Judith!!!

[Florian Perner @florian_perner]

We are hiring!
My laboratory at Hannover Medical School is searching for a motivated postdoc to join our team for the work on a highly competitive research project in the field of chromatin biology in pre-malignant hematopoiesis.
Interested? Apply here: https://t.co/Oo1QeL0oyr

[Tanaya Shree @tanaya_shree]

Great start to the new year - 2 papers in print this past week!

With @SarahHaebe, @gradycday, Ron Levy, and many others. #lymphoma #lymsm #bloodcancer #immunotherapy #FollicularLymphoma

[Sanjay Patel, MD @SanjayPatelMD]

Elated to end 2023 with our work featured on the cover of the latest issue of @BloodJournal! Thanks to the editors for selecting our study, and for the insightful commentary by @oscarbruck! #hematopoiesis #stemcells #bonemarrow #ArtificialIntelligence
https://t.co/LLlHCXUb0U

[Stefan Alig @StefanAlig]

Very proud to have contributed to this massive effort of #ctDNA profiling of classic Hodgkin lymphoma published in @Nature today during #ASH23 @mohamshah #AndreaGarofalo #MichaelYuLi
@AshAlizadeh @max_diehn

[Ash Alizadeh, MD/PhD 🇺🇸 @AshAlizadeh]

Thrilled to share our new study describing distinct subtypes of #HodgkinLymphoma #cHL out today @Nature. #lymsm 1/15
https://t.co/FOBvWSu5Je PDF link at bottom of this thread

[Sarah Haebe @SarahHaebe]

@StefanAlig @Nature @mohamshah @AshAlizadeh @max_diehn Great work! Congrats @StefanAlig and team!

[Sarah Haebe @SarahHaebe]

@NIH @LLSusa @Krebshilfe_Bonn @LMU_Uniklinikum @LMU_HaemOnk and of course @StanfordMed

[Sarah Haebe @SarahHaebe]

1/ Exited to share our new study on acquired N-linked glycosylation motifs in follicular lymphoma #FL out now in @BloodJournal
https://t.co/SRjQO4Aijr

[Sarah Haebe @SarahHaebe]

We are honored to have had support of @NIH @LLSusa @Krebshilfe_Bonn @LMU_Uniklinikum @LMU_HaemOnk

[Sarah Haebe @SarahHaebe]

@PhilRauchMD @florian_perner Juhu! Congrats Philipp!

[Sarah Haebe @SarahHaebe]

@KPekayvaz @ImmunityCP Congrats Kami and team!

[Kami Pekayvaz @KPekayvaz]

1/ How are macrophages sustained within the vascular niche?
We are happy to share our work @ImmunityCP showing how smooth muscle cells and pericytes provide a protective niche to safeguard vascular macrophages and limit atherosclerosis.

[Stefan Alig @StefanAlig]

Glad to see this out in print. Great work @hjcherng. Proud to have contributed! @AshAlizadeh @Lymphoma_Doc #lymsm #ctDNA

[Elizabeth McKenna @ElizSMcKenna]

Now in @CD_AACR: Tracing Founder Mutations in Circulating & Tissue-resident #FollicularLymphoma Precursors by @schroersmartin Joanne Soo @gabriel_brisou @FSchererMD Bertrand Nadel @SRoulland @max_diehn @AshAlizadeh et al. @CIML_Immunology @StanfordCancer https://t.co/TEIj4kRyFB

[Sarah Haebe @SarahHaebe]

#TRTH A stellar mentoring program! Thanks to @ASH_hematology, @EHA_Hematology, faculty and staff!

[European Hematology Association @EHA_Hematology]

The EHA-@ASH_hematology #TRTH 2023 spring course has ended. We congratulate all the scholars who took part on their hard work, developing projects, & new connections. We also thank the faculty for facilitating this journey. We look forward to reconnecting at #EHA2023.